BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19095263)

  • 41. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.
    Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Hirayama T; Okayasu I; Baba S
    Urology; 2007 May; 69(5):839-42. PubMed ID: 17482918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
    Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
    J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
    Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
    J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.
    Zini L; Destrieux-Garnier L; Leroy X; Villers A; Haulon S; Lemaitre L; Koussa M
    J Urol; 2008 Feb; 179(2):450-4; discussion 454. PubMed ID: 18076946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.
    Haferkamp A; Bedke J; Vetter C; Pritsch M; Wagener N; Buse S; Crnkovic-Mertens I; Hoppe-Seyler K; Macher-Goeppinger S; Hoppe-Seyler F; Autschbach F; Hohenfellner M
    BJU Int; 2008 Dec; 102(11):1700-6. PubMed ID: 18990137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma.
    Rasmuson T; Grankvist K; Jacobsen J; Olsson T; Ljungberg B
    Acta Oncol; 2004; 43(8):744-8. PubMed ID: 15764220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does renal capsular invasion have any prognostic value in localized renal cell carcinoma?
    Süer E; Ergün G; Baltaci S; Bedük Y
    J Urol; 2008 Jul; 180(1):68-71. PubMed ID: 18485385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
    Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
    Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma.
    Hotakainen K; Ljungberg B; Paju A; Rasmuson T; Alfthan H; Stenman UH
    Br J Cancer; 2002 Jan; 86(2):185-9. PubMed ID: 11870503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
    Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
    Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of erythropoietin expression in human renal cell carcinoma.
    Michael A; Politi E; Havranek E; Corbishley C; Karapanagiotou L; Anderson C; Relph K; Syrigos KN; Pandha H
    BJU Int; 2007 Aug; 100(2):291-4. PubMed ID: 17617137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
    Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
    Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
    J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.